Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Kudaba, I."'
Background: Pembrolizumab is active in head and neck squamous cell carcinoma (HNSCC), with programmed cell death ligand 1 (PD-L1) expression associated with improved response. Methods: KEYNOTE-048 was a randomised, phase 3 study of participants with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::25cb1f03a8d1b22885303ced3a20f10f
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3121788
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3121788
Autor:
Cho, B.C., Wu, Y., Lopes, G., Kudaba, I., Kowalski, D.M., Turna, H.Z., De Castro, G., Jr, Caglevic, C., Zhang, L., Karaszewska, B., Laktionov, K.K., Srimuninnimit, V., Bondarenko, I., Kubota, K., Yin, L., Lin, J., Souza, F., Mok, T.S.K.
Publikováno v:
In Journal of Thoracic Oncology March 2021 16(3) Supplement:S225-S226
Autor:
Subramanian, J., Jaal, J., Kudaba, I., Nikolov, K., Radosavljevic, D., Csőszi, T., Xiao, J., Horton, J., Malik, R.K., Gómez, M.D.
Publikováno v:
In Journal of Thoracic Oncology January 2021 16(1) Supplement:S33-S33
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ozguroglu, M., Shitara, K., Lee, K-W., Fuchs, C.S., Chung, H.C., Di Bartolomeo, M., Chao, J., Wainberg, Z.A., Caglevic, C., Kudaba, I., Van Custem, E., Garrido, M., Lee, J., Ma, J., Cao, Z.A., Shah, S., Shih, C-S., Bhagia, P., Wyrwicz, L., Tabernero, J.
Publikováno v:
In Annals of Oncology September 2020 31 Supplement 4:S915-S915
Autor:
Wyrwicz, L.S., Lee, K-W., Van Cutsem, E., Bang, Y-J., Fuchs, C.S., Kudaba, I., Garrido, M., Chung, H.C., Lee, J., Castro, H.R., Chao, J., Wainberg, Z.A., Cao, Z.A., Aurora-Garg, D., Kobie, J., Cristescu, R., Bhagia, P., Shah, S., Tabernero, J., Shitara, K.
Publikováno v:
In Annals of Oncology September 2020 31 Supplement 4:S907-S908
Autor:
Chung, H.C., Bang, Y.-J., Tabernero, J., Van Cutsem, E., Fuchs, C.S., Wyrwicz, L., Lee, K.-W., Kudaba, I., Garrido, M., Castro, H., Mansoor, W., Braghiroli, M.I., Goekkurt, E., Chao, J., Wainberg, Z.A., Kher, U., Shah, S., Shitara, K.
Publikováno v:
In Annals of Oncology November 2019 30 Supplement 9:ix43-ix44
Autor:
Shitara, K. 1, Van Cutsem, E. 2, Bang, Y.-J. 3, Fuchs, C.S. 4, Wyrwicz, L. 5, Lee, K.W. 6, Kudaba, I. 7, Garrido, M. 8, Cheol Chung, H. 9, Castro, H.R. 10, Mansoor, W. 11, Braghiroli, M I F M 12, Goekkurt, E. 13, Chao, J. 14, Wainberg, Z.A. 15, Kher, U. 16, Shah, S. 16, Kang, S.P. 16, Tabernero, J. 17
Publikováno v:
In Annals of Oncology October 2019 30 Supplement 5:v878-v879
Autor:
Daniel, D. 1, Kuchava, V. 2, Bondarenko, I. 3, Ivashchuk, O. 4, Spigel, D. 5, Dasgupta, A. 6, Reddy, S. 7, Melkadze, T. 8, Jaal, J. 9, Kudaba, I. 10, Hart, L. 11, Matitashvili, A. 12, Koynov, K.D. 13, Yang, Z. 14, Wolfe, S.G. 15, Malik, R. 16, Morris, S.R. 17, Antal, J.M. 17, Goldschmidt, J. 18
Publikováno v:
In Annals of Oncology October 2019 30 Supplement 5:v713-v713
Autor:
Tabernero, J., Van Cutsem, E., Bang, Y., Fuchs, C., Wyrwicz, L., Lee, K., Kudaba, I., Garrido, M., Chung, H., Castro Salguero, H., Mansoor, W., Braghiroli, M., Goekkurt, E., Chao, J., Wainberg, Z., Kher, U., Shah, S., Kang, S., Shitara, K.
Publikováno v:
In Annals of Oncology July 2019 30 Supplement 4:iv152-iv153